rivastigmine patch
Selected indexed studies
- Rivastigmine transdermal patch: a review of its use in the management of dementia of the Alzheimer's type. (Drugs, 2011) [PMID:21711064]
- Pharmacokinetic rationale for the rivastigmine patch. (Neurology, 2007) [PMID:17646618]
- Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementia. (Prim Care Companion CNS Disord, 2014) [PMID:25667813]
_Worker-drafted node — pending editorial review._
Connections
rivastigmine patch is a side effect of
Sources
- Rivastigmine transdermal patch: a review of its use in the management of dementia of the Alzheimer's type. (2011) pubmed
- Pharmacokinetic rationale for the rivastigmine patch. (2007) pubmed
- Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementia. (2014) pubmed
- Spotlight on rivastigmine transdermal patch: in dementia of the Alzheimer's type. (2011) pubmed
- Long-term effectiveness of rivastigmine patch or capsule for mild-to-severe Alzheimer's disease: a meta-analysis. (2015) pubmed
- A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia. (2007) pubmed
- Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trials. (2010) pubmed
- Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch. (2010) pubmed
- Skinfold thickness for rivastigmine patch application in Alzheimer's disease. (2019) pubmed
- Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review. (2009) pubmed